The SARS-CoV-2/Influenza A+B/RSV Antigen Combo Rapid Test is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 Nucleocapsid protein, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV) antigens in human nasopharyngeal or nasal
swab specimens from individuals with suspected SARS-CoV-2/Influenza/RSV infection in conjunction with clinical presentation and the results of other laboratory tests.
Product Features
Fast results
Easy visual interpretation
Simple operation, no equipment required
High accuracy
PRODUCT SPECIFICATION
- PrincipleChromatographic Immunoassay
- FormatCassette
- SpecimenSwab
- CertificateCE
- Reading Time15 minutes
- Pack20 T
-
Storage Temperature
2-30°C
- Shelf Life2 Years
- SensitivityNasopharyngeal Swab Specimen: 97.0%(SARS-CoV-2) / 95.0%(Influenza A) / 92.9%(Influenza B) / 94.3%(RSV) Nasal Swab Specimen: 97.0%(SARS-CoV-2) / 95.0%(Influenza A) / 92.9%(Influenza B) / 94.3%(RSV)
- SpecificityNasopharyngeal Swab Specimen: 99.0%(SARS-CoV-2) / 99.1%(Influenza A) / 99.1%(Influenza B) / 96.2%(RSV) Nasal Swab Specimen: 99.6%(SARS-CoV-2) / 99.6%(Influenza A) / 99.4%(Influenza B) / 99.7%(RSV)
- AccuracyNasopharyngeal Swab Specimen: 98.0%(SARS-CoV-2) / 98.4%(Influenza A) / 98.1%(Influenza B) / 95.9%(RSV) Nasal Swab Specimen: 98.9%(SARS-CoV-2) / 99.1%(Influenza A) / 98.9%(Influenza B) / 99.2%(RSV)
Ordering Information
- Cat. No.ISIR-535
- ProductSARS-CoV-2/Influenza A+B/RSV Antigen Combo Rapid Test
- Specimen Nasopharyngeal Swab
- Pack20 T
- Cut-OffSee Insert
